Table 1 Baseline characteristics of all patients
|  | All patients (n = 176) | EVO group (n = 90, 51.1%) | RTO group (n = 86, 48.9%) | P value |
|---|---|---|---|---|
Age | 60.3 ± 11.7 | 60.5 ± 11.9 | 59.5 ± 11.7 | 0.704 |
Male, n (%) | 125 (71.0) | 69 (76.7) | 56 (65.1) | 0.091 |
Etiology, n (%) | Â | Â | Â | 0.395 |
 Hepatitis B virus | 50 (28.4) | 22 (24.4) | 28 (32.6) |  |
 Hepatitis C virus | 14 (8.0) | 7 (7.8) | 7 (8.1) |  |
 Alcohol | 83 (47.2) | 48 (53.3) | 35 (40.7) |  |
 Other | 29 (16.5) | 13 (14.4) | 16 (18.6) |  |
Diabetes, n (%) | 50 (28.4) | 24 (26.4) | 26 (30.2) | 0.298 |
Hepatocellular carcinoma, n (%) | 50 (28.4) | 24 (26.7) | 26 (30.2) | 0.600 |
Type of varices, n (%) | Â | Â | Â | 0.470 |
 GOV2 | 99 (56.3) | 53 (58.9) | 46 (53.5) |  |
 IGV1 | 77 (43.7) | 37 (41.1) | 40 (46.5) |  |
Size of esophageal varices, n (%) | Â | Â | Â | 0.244 |
 F0–F1 | 102 (58.0) | 47 (52.2) | 55 (64.0) |  |
 F2–F3 | 74 (42.0) | 43 (47.8) | 31 (36.0) |  |
 Hemoglobin, g/dL | 9.0 ± 5.3 | 8.9 ± 2.2 | 9.1 ± 2.4 | 0.504 |
 Platelet count, × 109/L | 103.1 ± 52.6 | 106.0 ± 45.5 | 100.4 ± 59.7 | 0.935 |
 INR | 1.43 ± 0.32 | 1.44 ± 0.36 | 1.41 ± 0.71 | 0.362 |
 Alanine aminotransferase, IU/L | 38.5 ± 49.7 | 42.1 ± 60.9 | 35.1 ± 34.5 | 0.418 |
 Total bilirubin, mg/dL | 2.1 ± 3.2 | 2.3 ± 3.7 | 1.8 ± 2.5 | 0.154 |
 Serum albumin, g/dL | 2.9 ± 0.2 | 2.9 ± 0.5 | 3.0 ± 0.5 | 0.274 |
 MELD score | 12.6 ± 4.7 | 13.5 ± 4.5 | 11.7 ± 4.8 | 0.016 |
 Beta-blockers, n (%) | 52 (29.5) | 11 (12.2) | 41 (47.7) | < 0.001 |